FindTrial
Sign In

Autologous Tumor Infiltrating Lymphocytes

BIOLOGICAL6 trials

Sponsors

Gregory Daniels, Vastra Gotaland Region, Zhiyong Huang, Shanghai Juncell Therapeutics

Conditions

Liver CancerLocally Advanced Refractory/Recurrent Head and Neck CancerLocally Advanced Refractory/Recurrent MelanomaMetastatic Cutaneous MelanomaMetastatic Head and Neck CancerMetastatic MelanomaMetastatic Uveal MelanomaNon Small Cell Lung Cancer

Phase 1

Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors
TerminatedNCT03991741
Gregory DanielsLocally Advanced Refractory/Recurrent Head and Neck Cancer, Locally Advanced Refractory/Recurrent Melanoma, Metastatic Head and Neck Cancer +1
Start: 2020-10-07End: 2023-01-26Updated: 2025-07-03
Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases
CompletedNCT04812470
Vastra Gotaland RegionMetastatic Cutaneous Melanoma, Metastatic Uveal Melanoma
Start: 2023-02-06End: 2025-05-26Updated: 2025-09-22
Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases
Not yet recruitingNCT05903937
Vastra Gotaland RegionMetastatic Cutaneous Melanoma, Uveal Melanoma
Start: 2027-01-31End: 2031-12-31Target: 6Updated: 2026-09-09
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver Cancer
RecruitingNCT06084299
Zhiyong HuangLiver Cancer
Start: 2020-05-27End: 2026-08-30Target: 16Updated: 2025-08-19
A Phase Ib Study of GC101 in NSCLC
RecruitingNCT06473961
Shanghai Juncell TherapeuticsNon Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic
Start: 2024-10-14End: 2028-07-01Target: 20Updated: 2026-08-05

Phase 2

A Phase II Study of GC101 in NSCLC
RecruitingNCT07560111
Shanghai Juncell TherapeuticsNon Small Cell Lung Cancer
Start: 2026-06-01End: 2029-06-01Target: 28Updated: 2026-08-05

Related Papers

Phase I trial of locoregional administration of autologous tumor-infiltrating lymphocytes in patients with uveal melanoma and liver metastases (the HAITILS trial).
2026-03-18